Display options
Cite
Comen E, Wojnarowicz P, Seshan VE, et al. TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. NPJ Breast Cancer. 2016;2:16009doi: 10.1038/npjbcancer.2016.9.
Comen, E., Wojnarowicz, P., Seshan, V. E., Shah, R., Coker, C., Norton, L., & Benezra, R. (2016). TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. NPJ breast cancer, 216009. https://doi.org/10.1038/npjbcancer.2016.9
Comen, Elizabeth, et al. "TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients." NPJ breast cancer vol. 2 (2016): 16009. doi: https://doi.org/10.1038/npjbcancer.2016.9
Comen E, Wojnarowicz P, Seshan VE, Shah R, Coker C, Norton L, Benezra R. TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients. NPJ Breast Cancer. 2016 Apr 20;2:16009. doi: 10.1038/npjbcancer.2016.9. eCollection 2016. PMID: 28721376; PMCID: PMC5515342.
Copy Download .nbib Format: NLM
Share it on

NPJ Breast Cancer. 2016 Apr 20;2:16009. doi: 10.1038/npjbcancer.2016.9. eCollection 2016.

TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients.

NPJ breast cancer

Elizabeth Comen, Paulina Wojnarowicz, Venkatraman E Seshan, Riddhi Shah, Courtney Coker, Larry Norton, Robert Benezra

Affiliations

  1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  2. Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

PMID: 28721376 PMCID: PMC5515342 DOI: 10.1038/npjbcancer.2016.9

Abstract

We have previously shown a novel antimetastatic role for neutrophils in the premetastatic lung of mice in models of breast cancer. Here we expand on those findings in the context of human breast cancer. We assessed the cytotoxicity of neutrophils from 90 newly diagnosed breast cancer patients, 24 ductal carcinoma

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. J Biol Chem. 2005 Sep 2;280(35):31109-15 - PubMed
  2. Arch Immunol Ther Exp (Warsz). 2011 Apr;59(2):79-87 - PubMed
  3. Nature. 2015 Jun 18;522(7556):349-53 - PubMed
  4. Cell Rep. 2015 Feb 3;10(4):562-73 - PubMed
  5. Leuk Res. 2002 Jan;26(1):67-81 - PubMed
  6. Cell. 2000 Jan 7;100(1):57-70 - PubMed
  7. Cancer Cell. 2009 Jan 6;15(1):35-44 - PubMed
  8. Nature. 2015 Dec 17;528(7582):413-7 - PubMed
  9. Cell. 2012 Jul 6;150(1):165-78 - PubMed
  10. Cancer Microenviron. 2015 Dec;8(3):125-58 - PubMed
  11. Cancer Cell. 2011 Sep 13;20(3):300-14 - PubMed
  12. Nat Cell Biol. 2006 Dec;8(12):1369-75 - PubMed
  13. Cancer Res. 2005 Oct 1;65(19):8905-11 - PubMed
  14. Immunotherapy. 2014;6(2):195-209 - PubMed
  15. J Natl Cancer Inst. 2015 Aug 18;107(10):null - PubMed
  16. Clin Med Res. 2009 Jun;7(1-2):4-13 - PubMed

Publication Types

Grant support